Gonzalez-Bulnes A, Santiago-Moreno J, Cocero M J, Lopez-Sebastian A
Dpto. de Reproduccion Animal, SGIT/INIA (MAPA), Madrid, Spain.
Theriogenology. 2000 Oct 15;54(7):1055-64. doi: 10.1016/s0093-691x(00)00414-3.
Ovarian follicular development was characterized in 24 Spanish Merino ewes to study effects of the follicular status and the FSH commercial product used on follicular growth and subsequent superovulatory response. Estrus was synchronized using 40 mg fluorogestone acetate sponges. The superovulatory treatment consisted in 2 daily i.m. injections of FSH from 48 h before to 12 h after sponge removal. Sheep were assigned randomly to 2 groups treated with 6 decreasing doses (4, 4, 3, 3, 2, 2 mg) of FSH-P or with 6 doses of 1.25 mL of OVAGEN. Growth and regression of all follicles > or = 2 mm were observed by transrectal ultrasonography, and recorded daily from Day 6 before sponge insertion to the first FSH injection, and then twice daily until estrus was detected with vasectomized rams. Differences were detected in follicular development from the first FSH injection to detection of estrus (-48 to 36 h from sponge removal) between groups. Administration of FSH-P increased the appearance of new follicles with respect to OVAGEN (6.3 +/- 0.7 vs 4.8 +/- 0.4; P < 0.05), and the mean number of medium (4 to 5 mm) follicles (8.9 +/- 1.2 vs 6.6 +/- 0.9; P < 0.05). However, the mean number of follicles that regressed in size after sponge removal (5.9 +/- 0.4 vs 3.3 +/- 0.4) and the number of preovulatory sized follicles that did not ovulate (60 vs 42.4%) were also higher in FSH-P treated ewes (P < 0.05). So, finally, there were no differences in ovulation rate, as determined by laparoscopy on Day 7 after sponge removal, between ewes treated with FSH-P or OVAGEN (6.3 +/- 1.9 vs 7.0 +/- 1.7 CL). In all the ewes, the ovulatory response was related (P < 0.05) both to the number of small follicles (2 to 3 mm in diameter) present in the ovaries at the start of treatment with exogenous FSH and to the number of follicles that reached > or = 4 mm in size at estrus, despite differences in the pattern of follicular development when using different commercial products.
对24只西班牙美利奴母羊的卵泡发育进行了表征,以研究卵泡状态和所使用的促卵泡素(FSH)商业产品对卵泡生长及随后的超排反应的影响。使用40毫克醋酸氟孕酮海绵同步发情。超排处理包括在取出海绵前48小时至取出后12小时每天肌肉注射两次FSH。将绵羊随机分为两组,一组用6个递减剂量(4、4、3、3、2、2毫克)的FSH-P处理,另一组用6剂1.25毫升的OVAGEN处理。通过经直肠超声观察所有直径≥2毫米卵泡的生长和退化情况,从插入海绵前第6天至首次注射FSH期间每天记录,之后每天记录两次,直至用输精管结扎公羊检测到发情。两组之间在首次注射FSH至检测到发情(取出海绵后-48至36小时)期间的卵泡发育存在差异。与OVAGEN相比,注射FSH-P增加了新卵泡的出现(6.3±0.7对4.8±0.4;P<0.05),以及中等大小(4至5毫米)卵泡的平均数量(8.9±1.2对6.6±0.9;P<0.05)。然而,取出海绵后大小退化的卵泡平均数量(5.9±0.4对3.3±0.4)以及未排卵的排卵前大小卵泡数量(60对42.4%)在FSH-P处理的母羊中也更高(P<0.05)。所以,最终,在取出海绵后第7天通过腹腔镜检查确定的排卵率在FSH-P处理和OVAGEN处理的母羊之间没有差异(6.3±1.9对7.0±1.7个黄体)。在所有母羊中,排卵反应与外源FSH处理开始时卵巢中存在的小卵泡(直径2至3毫米)数量以及发情时达到直径≥4毫米的卵泡数量均相关(P<0.05),尽管使用不同商业产品时卵泡发育模式存在差异。